Fusion protein SAmB as well as coding gene and applications thereof
A fusion protein and protein technology, applied in gene therapy, fusion polypeptide, fusion with toxin, etc., can solve problems such as limitations, technical difficulties, and protein instability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Embodiment 1, construction, expression and purification of recombinant fusion protein SAmB
[0031] The strains and plasmids used in the present invention are shown in Table 1 below; the primers used in the present invention are shown in Table 2 below. Ni affinity chromatography column HisTRAP FFTM and The FPLC purification system is a GE product.
[0032] Table 1. Bacterial strains and plasmids used in the experiments
[0033]
[0034] Table 2. Primer sequences used in experiments
[0035]
[0036] a The underlined part is a restriction endonuclease site.
[0037] b Linked sequences are underlined in bold font.
[0038] 1. Construction of recombinant expression vector
[0039] 1. Acquisition of the gene encoding the fusion protein
[0040] Use primers 1 and 2 to PCR amplify the A subunit protein gene (Stx2A gene) of type II Shiga toxin from the genome of EHEC O157:H7EDL933 (see Table 1 for the characteristics and origin of the strain) (shown in sequence ...
Embodiment 2
[0056] Example 2, the immunogenicity of the fusion protein SAmB and the in vitro anti-adhesion and anti-toxin activity of the immune serum
[0057] Reagents used in this example: Sorbitol MacConkey basic agar, MTT, and Gimsa dyes were all purchased from Kejunzhou; DMEM medium was purchased from GIBCO; standard fetal bovine serum was purchased from Biochrom; double antibodies were purchased from Hyclone; Cefixime granules were products of Guangzhou Baiyunshan General Pharmaceutical Factory, and 1% potassium tellurite was purchased from Beijing Luqiao Technology Co., Ltd. Experimental animals were purchased from the Experimental Animal Center of the Academy of Military Medical Sciences. Freund's complete adjuvant and Freund's incomplete adjuvant were purchased from SIGMA.
[0058] 2S protein is used as a positive control in the present invention to compare and evaluate the immunogenicity and protective effect of SAmB. 2S protein is a kind of fusion protein that is connected by...
Embodiment 3
[0070] Embodiment 3, the immunoprotective effect of fusion protein SAmB anti-EHEC O157:H7 infection
[0071] Animal immunization steps are the same as in Example 2.
[0072] Stx1 and Stx2, as two toxin proteins, are used in the present invention to challenge SAmB-immunized mice. Its preparation method sees with embodiment 2.
[0073] 1. Observation of the protective effect of the mice in the immunized group against the lethal dose of EHEC O157:H7 lytic bacteria challenge
[0074] Carry out 10LD50 lethal dose O157: H7 lytic bacteria challenge test (1LD50=10 through SAmB immune three times) 7 CFU), every group of 15 mice, 21 days statistical survival rate, the result 93.3% mice all showed to be protected (14 / 15), and placebo immunization group (PBS) 15 mice all died (0 / 15) ( Figure 5 A), Only 26.7% of mice survived in the 2S immunized group (4 / 15).
[0075] 2. Observation of the protective effect of the mice in the immunized group against the lethal dose of Stx toxin challe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com